Manas AI

The AI-Native Biopharmaceutical Company

Manas AI is a life sciences company in New York, United States, founded in 2025. It has raised $50.6M across 2 rounds, most recently a $26.0M Extension Round in September 2025.

Headquarters
New York, New York
Employees
1–10
Founded
2025
Business Model
B2B
Website
manasai.co
Total Funding
$50.6M
Last Round
$26.0M Extension RoundSep 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 8 investors for this company. to use credits for reveals, or explore the API.

About

Manas AI is an end-to-end, AI-native biopharmaceutical company founded on the mission to cure human disease. The company builds and uses neuro-symbolic, science-based foundational models to discover transformative medicines and bring them to market. Co-founded by Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh, Manas AI is headquartered in New York.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundSep 2025
$26.0M

1 more funding event

  • Seed20253 investors

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Life Sciences
Private EquityTotal funding$2.3BFeb 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Life Sciences
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Life Sciences
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Life Sciences
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Life Sciences
Series CTotal funding$630.0MJul 2026
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Life Sciences
Series CTotal funding$446.9MNov 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Manas AI on Indexed.vc
<a href="https://indexed.vc/companies/manas-ai"><img src="https://indexed.vc/api/badge/company/manas-ai" alt="Manas AI on Indexed.vc" width="260" height="76" /></a>